↓ Skip to main content

Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus

Overview of attention for article published in Arthritis Research & Therapy, June 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
3 X users
patent
6 patents

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus
Published in
Arthritis Research & Therapy, June 2012
DOI 10.1186/ar3881
Pubmed ID
Authors

Zahava Vadasz, Tharwat Haj, Katalin Halasz, Itzhak Rosner, Gleb Slobodin, Dina Attias, Aharon Kessel, Ofra Kessler, Gera Neufeld, Elias Toubi

Abstract

Semaphorin 3A (sema3A) and neuropilin-1 (NP-1) play a regulatory role in immune responses and have a demonstrated effect on the course of collagen induced arthritis. This study was undertaken to evaluate the role of sema3A and NP-1 in the pathogenesis of systemic lupus erythematosus (SLE) and the specific effect of sema3A on the auto-reactive properties of B cells in SLE patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 20%
Student > Ph. D. Student 7 17%
Student > Doctoral Student 3 7%
Professor > Associate Professor 3 7%
Student > Master 2 5%
Other 4 10%
Unknown 14 34%
Readers by discipline Count As %
Medicine and Dentistry 13 32%
Agricultural and Biological Sciences 9 22%
Immunology and Microbiology 2 5%
Biochemistry, Genetics and Molecular Biology 1 2%
Unknown 16 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 October 2020.
All research outputs
#4,572,992
of 25,374,917 outputs
Outputs from Arthritis Research & Therapy
#990
of 3,381 outputs
Outputs of similar age
#30,291
of 181,087 outputs
Outputs of similar age from Arthritis Research & Therapy
#8
of 76 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 181,087 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.